The Company
Sudden cardiac deaths (SCD), also known as sudden cardiac arrest, accounts for 10-15% of all deaths in adults (320,000-400,000 deaths each year in Europe) equivalent to the cumulative mortality of lung and breast cancers. The paradox is that efficient treatment options exist, such as implantable defibrillators. The major unsolved problem remains in how to non-invasively identify subjects at risk prior to death.
Pulsheart was founded in 2023 by Prof. Michel Haïssaguerre and colleagues from the Liryc research center (150+ international multidisciplinary experts in cardiology) to develop and validate software and hardware to tackle this major screening need, assess early a potential risk and prevent SCD.
The Position
We’re seeking passionate and versatile people who share our mission and want to grow with us — individuals who bring creativity, integrity, and resilience to every challenge, and who are excited to learn, collaborate, and innovate in a dynamic, multi-disciplinary environment.
What We Offer:
- Contribute to the solution of a major healthcare problem
- Work with a talented, excellent, diverse and international team
- Interact with a multi-disciplinary team of top researchers in signal processing, AI, biology and medicine
- Spend quality time in Bordeaux (South-West of France, close to the ocean, the mountains and good wine)
- Benefit from a competitive salary and an equity opportunity
Hybrid position possible according to profiles.